3rd MVF congress workshop: “Quo vadis vaccination rate?”

Greetings from the editor

Ladies and Gentlemen
Dear Colleagues,

With our online congress format “Vaccination Status – Vaccination in Times of Pandemic” we discussed with experts last year and recently in April why it may be that we in this country find it so difficult to take up the vaccinations recommended by the STIKO for risk groups . In the interesting lectures and discussions - the documentation of the online congresses 2021 (1) and 2022 (2) can be found at www.m-vf.de - the keyword “§ 132e SGB V” was mentioned, among other things. We will clarify what this means in detail in the online congress “Quo vadis vaccination quota? Wish and reality of Section 132e Paragraph 4 SGB V”, to which I would like to warmly invite you.

On June 30th, in a congress/workshop format, we want to address the question of the implementation of SGB-V Paragraph 132e on the provision of protective vaccinations, which will at least enable health insurance companies or their associations to do so According to the text of the law, the “statutory health insurance associations, doctors, institutions with medical staff, their communities” as well as the highest state health authorities or the bodies designated by them to carry out contracts for the implementation of protective vaccinations in accordance with Section 20i. This is particularly with regard to the vaccination guideline adopted by the G-BA on October 21, 21 as an implementation of the STIKO recommendation from August 2021 (published in Epidemiological Bulletin Number 34). Is Section 132e even applied? And if not: why not?
If one were to use it – this is the theory – the paragraph would be a means of increasing the vaccination rate in all of the indications recommended by the STIKO. What's the problem? What is to be done? Or: How else can the population's willingness to be vaccinated for many common diseases be increased?
Take the opportunity to enter into an intensive discussion with the experts.

With kind regards
Your professor Dr. Reinhold Roski
Publisher “Monitor Health Services Research”

Contact

If you have any questions about the workshop congress, please contact Anke Heiser

• per email to [email protected] or
• by phone at 0228 – 76 38 280-30

Speakers & Lectures

Here you can find the speakers (in chronological order) of the congress workshop “Quo vadis Vaccination Quota?”, which took place online on June 30, 2022. The lectures and their audio recordings are available open access to all interested parties (as soon as the speakers have approved them). Of course, we would be happy about every new subscriber who would show that our work is valued. You can read the documentation of the online event in the upcoming issue of MVF (04/22) as well as in an 8-page special print.

Congress Chair